Analysis of (n,2n) cross-section measurements for nuclei up to mass 238

All suitable measurements of the energy dependence of (n,2n) cross sections of all isotopes up to mass 238 have been analyzed. The objectives were to display the quality of the measured data for each isotope and to examine the systematic dependence of the (n,2n) cross section upon N, Z, and A. Graphs and tables are presented of the ratio of the asymptotic (n,2n) and nonelastic cross section to the neutron-asymmetry parameter (N--Z)/A. Similar data are presented for the derived nuclear temperature, T, and level-density parameter, $alpha$, as a function of N, Z, and A. This analysis of the results of over 145 experiments on 61 isotopes is essentially a complete review of the current status of (n,2n) cross-section measurements. (auth

Virtual Black Holes

One would expect spacetime to have a foam-like structure on the Planck scale with a very high topology. If spacetime is simply connected (which is assumed in this paper), the non-trivial homology occurs in dimension two, and spacetime can be regarded as being essentially the topological sum of $S^2\times S^2$ and $K3$ bubbles. Comparison with the instantons for pair creation of black holes shows that the $S^2\times S^2$ bubbles can be interpreted as closed loops of virtual black holes. It is shown that scattering in such topological fluctuations leads to loss of quantum coherence, or in other words, to a superscattering matrix $\$$ that does not factorise into an $S$ matrix and its adjoint. This loss of quantum coherence is very small at low energies for everything except scalar fields, leading to the prediction that we may never observe the Higgs particle. Another possible observational consequence may be that the $\theta$ angle of QCD is zero without having to invoke the problematical existence of a light axion. The picture of virtual black holes given here also suggests that macroscopic black holes will evaporate down to the Planck size and then disappear in the sea of virtual black holes.Comment: 24p, LaTeX, 3 postscript figures included with epsf sent in a seperate uuencoded fil

Dielectronic Recombination in He+ Ions

This research was sponsored by the National Science Foundation Grant NSF PHY-931478

Phocine Distemper Outbreak, the Netherlands, 2002

During the 2002 phocine distemper epidemic, 2,284 seals, primarily harbor seals (Phoca vitulina), were found stranded along the Dutch coast. Stranding pattern varied with age, sex, state of decomposition, wind, and location. Cumulative proportion of deaths (54%) was comparable to that in the first reported epidemic in 1988

The ASSURE study: HIV-1 suppression is maintained with bone and renal biomarker improvement 48 weeks after ritonavir discontinuation and randomized switch to abacavir/lamivudine+atazanavir

Objectives: HIV treatment guidelines endorse switching or simplification of antiretroviral therapy in therapy-experienced patients with suppressed viraemia; ritonavir discontinuation may also enhance tolerability and reduce long-term adverse events (AEs). This open-label, multicentre, noninferiority study enrolled HIV-1-infected, treatment-experienced adults with confirmed HIV-1 RNA≤75 HIV-1 RNA copies/mL currently receiving tenofovir/emtricitabine+atazanavir/ritonavir (TDF/FTC+ATV/r) for ≥6 months with no reported history of virological failure. Methods: Participants were randomized 1:2 to continue current treatment or switch to abacavir/lamivudine + atazanavir (ABC/3TC+ATV). Endpoints included the proportion of participants with HIV-1 RNA<50 copies/mL by time to loss of virological response (TLOVR), AEs, fasting lipids, and inflammatory, coagulation, bone and renal biomarkers. Results: After 48 weeks, 76% (152 of 199) of ABC/3TC+ATV-treated and 79% (77 of 97) of TDF/FTC+ATV/r-treated participants had HIV-1 RNA<50 copies/mL (TLOVR; P=0.564). Other efficacy analyses yielded similar results. Rates of new grade 2-4 AEs were 45% in both groups, but an excess of hyperbilirubinaemia made the rate of treatment-emergent grade 3-4 laboratory abnormalities higher with TDF/FTC+ATV/r (36%) compared with ABC/3TC+ATV (19%). Most fasting lipid levels remained stable over time; high-density lipoprotein (HDL) cholesterol increased modestly in ABC/3TC+ATV-treated participants. Bone and renal biomarkers improved significantly between baseline and week 48 in participants taking ABC/3TC+ATV and were stable in participants taking TDF/FTC+ATV/r. No significant changes occurred in any inflammatory or coagulation biomarker within or between treatment groups. Conclusions: The ABC/3TC+ATV treatment-switch group had similar viral suppression rates up to 48 weeks to the TDF/FTC+ATV/r comparator group, with lower rates of moderate- to high-grade hyperbilirubinaemia and improvements in bone and renal biomarkers